Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0095 (-95.00%)
At close: Dec 26, 2025
Actavia Life Sciences Statistics
Total Valuation
RASP has a market cap or net worth of 385,906.
| Market Cap | 385,906 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RASP has 771.81 million shares outstanding.
| Current Share Class | 771.81M |
| Shares Outstanding | 771.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -427.68% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 15.83% |
| Weighted Average Cost of Capital (WACC) | -271.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -406,646 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.50% in the last 52 weeks. The beta is -91.39, so RASP's price volatility has been lower than the market average.
| Beta (5Y) | -91.39 |
| 52-Week Price Change | -87.50% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 44.60 |
| Average Volume (20 Days) | 10,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -345,267 |
| Pretax Income | -406,646 |
| Net Income | -406,646 |
| EBITDA | n/a |
| EBIT | -345,267 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 1,392 in cash and 303,962 in debt, with a net cash position of -302,570 or -0.00 per share.
| Cash & Cash Equivalents | 1,392 |
| Total Debt | 303,962 |
| Net Cash | -302,570 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -2.18M |
| Book Value Per Share | -0.00 |
| Working Capital | -2.18M |
Cash Flow
| Operating Cash Flow | -66,444 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RASP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -186.81% |
| Shareholder Yield | -186.81% |
| Earnings Yield | -105.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 20, 2016. It was a forward split with a ratio of 3.25.
| Last Split Date | Sep 20, 2016 |
| Split Type | Forward |
| Split Ratio | 3.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |